{"id":"W4402494964","doi":"10.1038/s41523-024-00679-7","title":"Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Breast Cancer Foundation; Breast Cancer Research Foundation","keywords":"Pembrolizumab; Oncology; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002906122,0.0002531791,0.0006805791,0.0000617839,0.00008140607,0.00003550354,0.0001626195,0.00007589122,0.0002512049],"category_scores_gemma":[0.00003013455,0.0001345215,0.0002288321,0.0002689128,0.0001606301,0.00009175974,0.00001705919,0.0001581019,0.000002350241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002476682,"about_ca_system_score_gemma":0.0003430797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002151915,"about_ca_topic_score_gemma":0.0003851362,"domain_scores_codex":[0.9983011,0.00007965147,0.0004895122,0.0004446452,0.000430229,0.0002548303],"domain_scores_gemma":[0.9987448,0.0003371021,0.0001754174,0.0004684505,0.0002103602,0.00006390832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7960966,0.0003857267,0.001178834,0.00006573508,0.001623312,0.00000483043,0.004262264,0.00002109538,0.0003002585,0.000007738056,0.00224648,0.1938072],"study_design_scores_gemma":[0.8057844,0.001180312,0.1784491,0.0008398788,0.0006991841,0.000007966366,0.001065537,0.0004207083,0.0004471594,0.00004607896,0.01077553,0.0002841238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835616,0.002317113,0.0001711635,0.006785038,0.0006716936,0.004439123,0.001380299,0.00008932005,0.0005846266],"genre_scores_gemma":[0.9972268,0.0002370249,0.0001375083,0.0008879655,0.0003281154,0.0005881168,0.0001128158,0.00006336383,0.000418232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.193523,"threshold_uncertainty_score":0.5485629,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008130626764051447,"score_gpt":0.2726968127594168,"score_spread":0.2645661859953653,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}